ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Galapagos Compound Unit Goes To Evotec

by Rick Mullin
June 6, 2011 | APPEARED IN VOLUME 89, ISSUE 23

Evotec has spent approximately $18 million to acquire Galapagos’ Compound Focus compound management unit. Located in South San Francisco, the business specializes in acquiring, formatting, storing, and shipping compound libraries for drug research labs (C&EN, April 11, page 24). It had sales of about $11 million last year. Evotec CEO Werner Lanthaler says the acquisition will strengthen his company’s existing compound management services and enhance its compound-screening platform. Galapagos says it will concentrate on drug discovery services through its Bio­Focus and Argenta businesses.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment